PubRank

Georgiana K Ellis

Author PubWeight™ 23.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 HER-2 testing in breast cancer using parallel tissue-based methods. JAMA 2004 4.60
2 Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol 2006 2.12
3 Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med 2003 2.06
4 Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med 2002 1.87
5 Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 2008 1.60
6 Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP). Breast Cancer Res Treat 2007 1.48
7 Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 2004 1.31
8 PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake. Clin Cancer Res 2011 1.12
9 Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival. Cancer 2005 1.09
10 Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC). Am J Clin Oncol 2004 1.08
11 The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors. J Natl Compr Canc Netw 2009 1.03
12 Myalgias and arthralgias associated with paclitaxel. Oncology (Williston Park) 2003 1.02
13 Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer. Clin Cancer Res 2011 0.98
14 [Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow. Nucl Med Biol 2002 0.91
15 Amphiphysin paraneoplastic syndrome: a delayed diagnosis of breast carcinoma. Breast J 2003 0.82
16 Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab. Clin Med Insights Oncol 2012 0.79
17 Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012). Breast Cancer Res Treat 2010 0.76